Jane Huang - Net Worth and Insider Trading

Jane Huang Net Worth

The estimated net worth of Jane Huang is at least $28 Million dollars as of 2024-05-18. Jane Huang is the CMO, Hematology of BeiGene Ltd and owns about 160,055 shares of BeiGene Ltd (BGNE) stock worth over $28 Million. Jane Huang is also the President, CMO of Prelude Therapeutics Inc and owns about 24,220 shares of Prelude Therapeutics Inc (PRLD) stock worth over $96,880. Details can be seen in Jane Huang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jane Huang has not made any transactions after 2023-04-06 and currently still holds the listed stock(s).

Transaction Summary of Jane Huang

To

Jane Huang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jane Huang owns 3 companies in total, including BeiGene Ltd (BGNE) , Protara Therapeutics Inc (TARA) , and Prelude Therapeutics Inc (PRLD) .

Click here to see the complete history of Jane Huang’s form 4 insider trades.

Insider Ownership Summary of Jane Huang

Ticker Comapny Transaction Date Type of Owner
BGNE BeiGene Ltd 2021-12-14 CMO & Hematology
TARA Protara Therapeutics Inc 2021-06-09 director
PRLD Prelude Therapeutics Inc 2023-04-06 President & CMO

Jane Huang Latest Holdings Summary

Jane Huang currently owns a total of 2 stocks. Among these stocks, Jane Huang owns 160,055 shares of BeiGene Ltd (BGNE) as of December 14, 2021, with a value of $28 Million and a weighting of 99.65%. Jane Huang also owns 24,220 shares of Prelude Therapeutics Inc (PRLD) as of April 6, 2023, with a value of $96,880 and a weighting of 0.35%.

Latest Holdings of Jane Huang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BGNE BeiGene Ltd 2021-12-14 160,055 172.85 27,665,507
PRLD Prelude Therapeutics Inc 2023-04-06 24,220 4.00 96,880

Holding Weightings of Jane Huang


Jane Huang Form 4 Trading Tracker

According to the SEC Form 4 filings, Jane Huang has made a total of 38 transactions in BeiGene Ltd (BGNE) over the past 5 years, including 0 buys and 38 sells. The most-recent trade in BeiGene Ltd is the sale of 1,500 shares on December 14, 2021, which brought Jane Huang around $417,210.

According to the SEC Form 4 filings, Jane Huang has made a total of 1 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Prelude Therapeutics Inc is the sale of 13,280 shares on April 6, 2023, which brought Jane Huang around $81,274.

Insider Trading History of Jane Huang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jane Huang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jane Huang Ownership Network

Ownership Network List of Jane Huang

No Data

Ownership Network Relation of Jane Huang


Jane Huang Owned Company Details

What does BeiGene Ltd do?

Who are the key executives at BeiGene Ltd?

Jane Huang is the CMO & Hematology of BeiGene Ltd. Other key executives at BeiGene Ltd include director & 10 percent owner & Chief Executive Office John Oyler , Chief Financial Officer Julia Aijun Wang , and director & 10 percent owner Baker Bros. Advisors Lp .

BeiGene Ltd (BGNE) Insider Trades Summary

Over the past 18 months, Jane Huang made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 130,000 shares made by John Oyler , a net sale of 80,648 shares made by Xiaodong Wang , and a net sale of 13,539 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 100,397 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 100,397 shares. During the past 18 months, 5,485,167 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,485,167 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BeiGene Ltd Insider Transactions

No Available Data

Jane Huang Mailing Address

Above is the net worth, insider trading, and ownership report for Jane Huang. You might contact Jane Huang via mailing address: C/o Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman E9 Ky1-1108.

Discussions on Jane Huang

No discussions yet.